Teleflex Medical Launches Hybrid Universal OSA Interface
 |
|
 |
23 June 2006, 2:15pm ET
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--June 23,
2006--Teleflex Medical announced today the launch of the
Hybrid(TM),
a revolutionary interface for use with sleep therapy systems for the
treatment of obstructive sleep apnea. The Hybrid interface is a
unique fusion of technologies designed to be a universal interface
for patients, clinicians and providers. This one product serves as a
nasal interface, an oral interface, and a combination of the two.
Its proprietary design enhances patient comfort and compliance by
eliminating pressure points on the forehead and across the bridge of
the nose.
"We at Teleflex Medical are excited to bring this innovative
technology to market," said Tim Hopper, vice president and general
manager of the Medical Products business unit, Teleflex Medical.
"The proprietary design of the Hybrid redefines the management of
obstructive sleep apnea by providing optimal patient comfort
resulting in greater therapy compliance. As a result, the Hybrid
will transform the way OSA management is viewed moving forward."
The Hybrid joins Teleflex Medical's existing family of
Nasal-Aire(R)
II sleep therapy interfaces. The Nasal-Aire II features an
innovative design that looks, wears and feels like an oversized
oxygen cannula. The product is available in standard and petite
sizes, making it suitable for a wide range of patients.
Teleflex Medical, a division of Teleflex Incorporated, is a leading
global supplier of disposable medical products, surgical instruments
and medical devices. The division supports health providers along
the continuum of care in three main areas:
-- Devices for sleep therapy, respiratory care, anesthesia and
urology
-- Surgical instruments, reusable and disposable surgical devices
specializing in ligation and wound closure and devices for
cardiac and thoracic surgery
-- Original equipment manufacturers
Teleflex Medical markets health care supplies under the Hudson RCI
and Rusch brand names and surgical instruments and medical devices
under the Beere, Deknatel, KMedic, Pilling and Weck brands. In 2005,
Teleflex Medical had revenues of $831 million.
About Teleflex Incorporated
Teleflex Incorporated (NYSE:TFX) is a diversified company with 2005
annual revenues of $2.5 billion. Teleflex designs, manufactures and
distributes quality engineered products and services for the
aerospace, automotive, marine, industrial and medical markets
worldwide. Headquartered in Limerick, Pa., with operations in 24
countries, Teleflex employs more than 20,000 people worldwide who
focus on providing innovative solutions for customers. Additional
information about Teleflex can be obtained from the Company's
website on the Internet at www.teleflex.com .
To learn more about Teleflex Medical's line of sleep therapy
products visit
www.teleflexmedical.com or
www.hudsonrci.com.
Forward-looking information:
Statements in this news release, other than historical data, are
considered forward-looking statements under the Private Securities
Litigation Reform Act of 1995. These statements are subject to
various risks and uncertainties that could cause actual results to
differ from those contemplated in the statements. Actual results
could differ materially from those in these forward-looking
statements; please refer to Teleflex's filings with the Securities
and Exchange Commission.
Hybrid(TM) is a trademark of RespCare Inc. Nasal-Aire is a
registered trademark of InnoMed Technologies, Inc.
CONTACT: Teleflex Medical
Whitney Reynolds, 919-433-4811
wreynolds@teleflexmedical.com
SOURCE: Teleflex Medical
|
|
